| 1 |
Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS. Fibrate-associated adverse effects beyond muscle and liver toxicity. Curr Pharm Des. 2008; 14(6): 574-87.
doi: 10.2174/138161208783885362
|
| 2 |
Fenofibrate. In: TOXBASE. Available at: www.toxbase.org/poisons-index-a-z/f-products/fenofibrate------------/
|
| 3 |
Fombon I. Fenofibrate toxicity and impact on clinical biomarkers in patients with dyslipidaemia. (Thesis). University of the West of England. Available at: https://uwe-repository.worktribe.com/output/3829730
|
| 4 |
Metformin. In: TOXBASE. Available at: https://www.toxbase.org/poisons-index-a-z/m-products/metformin- - - - - - - - - - - - - -/
|
| 5 |
Jagia M, Taqi S, Hanafi M. Metformin poisoning: a complex presentation. Indian J Anaesth. 2011; 55(2): 190-2.
doi: 10.4103/0019-5049.79890
pmid: 21712882
|
| 6 |
Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA. 2012; 308(8): 804-11.
doi: 10.1001/jama.2012.8439
pmid: 22910758
|
| 7 |
Sevencan NO, Ozkan AE, Kayhan B. Linagliptin-related pancreatitis in a diabetic patient with biliary calculus: a case report. Medicine. 2018; 97(50): e13284.
|
| 8 |
Mallick S. Metformin induced acute pancreatitis precipitated by renal failure. Postgrad Med J. 2004; 80(942): 239-40.
pmid: 15082849
|
| 9 |
Damughatla AR, Surapaneni S, Wadehra A, Kabashneh S, Shanah L. A novel case of metformin-induced pancreatitis in an individual with normal dosing and no underlying chronic kidney disease. Cureus. 2022; 14(5): e25116.
|
| 10 |
Kassim T, Hermes JM, Abdussalam A, Aly A, Chandra S. Fenofibrate: a nonlithogenic means of recurrent drug-induced pancreatitis. Case Rep Gastrointest Med. 2018; 2018: 1-5.
|
| 11 |
Expert Panel on Detection E. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285(19): 2486-97.
|
| 12 |
Huang A, Motayar N, Quill C. 1721: Successful reversal of metformin-induced vasoplegic shock: never too blue with methylene blue. Crit Care Med. 2019; 47: 834.
|
| 13 |
Ling H, Luoma JT, Hilleman D. A review of currently Available fenofibrate and fenofibric acid formulations. Cardiol Res. 2013; 4(2): 47-55.
|
| 14 |
Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn’s disease. Gastroenterology. 1986; 90(4): 1039-41.
pmid: 3081397
|
| 15 |
Rebecca Campbell RD, Katherine Liu MD. Total parenteral nutrition during acute pancreatitis: clinical experience with 156 patients. World J Surg. 1990; 14(5): 572-9.
pmid: 2122603
|
| 16 |
Gianotti L, Meier R, Lobo DN, Bassi C, Dejong CHC, Ockenga J, et al. ESPEN guidelines on parenteral nutrition: pancreas. Clin Nutr. 2009; 28(4): 428-35.
doi: 10.1016/j.clnu.2009.04.003
pmid: 19464771
|
| 17 |
Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006; 105(1): 217-8.
doi: 10.1097/00000542-200607000-00033
pmid: 16810015
|
| 18 |
Patel KS, Noel P, Singh VP. Potential influence of intravenous lipids on the outcomes of acute pancreatitis. Nutr Clin Pract. 2014; 29(3): 291-4.
doi: 10.1177/0884533614527774
pmid: 24687866
|
| 19 |
Yang KC, Fang CC, Su TC, Lee YT. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD. Am J Kidney Dis. 2005 ;45(3): e57-e60.
|
| 20 |
Juneja D, Nasa P, Jain R. Metformin toxicity: a meta-summary of case reports. World J Diabetes. 2022; 13(8): 654-64.
doi: 10.4239/wjd.v13.i8.654
pmid: 36159225
|
), Paul Yugendra1, Yiju Yao2, R Ponampalam1, Boon Kiat Kenneth Tan1
